Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3033

Actual shortage: 243 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VERAP TABLET 120MG 120MG TABLET Actual shortage 2024-04-12 2024-04-26 225017
APO-VERAP TAB 80MG 80MG TABLET Resolved 2018-05-02 2018-07-12 47972
APO-VERAP TAB 80MG 80MG TABLET Resolved 2019-03-13 2019-04-05 78555
APO-VERAP TAB 80MG 80MG TABLET Resolved 2023-02-23 2023-03-02 185462
APO-VERAP TAB 80MG 80MG TABLET Resolved 2023-08-12 2023-09-29 201713
APO-VERAP TAB 80MG 80MG TABLET Resolved 2024-02-02 2024-04-19 218394
APO-VERAP SR 240MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 255
APO-VERAP SR 180MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 260
APO-VERAP SR 120MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-11 2019-12-04 552
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-16 2018-03-08 10442
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2017-07-25 2018-03-08 16886
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-09-27 2018-03-08 23658
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-04-10 2018-11-03 45353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-03-08 69458
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-12-23 69460
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-18 2019-05-21 82022
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2022-05-16 86341
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-06-24 86364

Showing 121 to 140 of 3033

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71048
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71051
APO-VALSARTAN/HCTZ 12.5MG 160MG TABLET Discontinued 2019-01-03 2019-01-03 71054
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71057
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71032
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71035
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71038
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-VALGANCICLOVIR 450MG TABLET Discontinued 2018-09-08 2018-09-15 60843
APO-VALACYCLOVIR 500MG TABLET Discontinued 2018-09-08 2018-09-15 60840
APO-TRAZODONE TABLETS 50MG 50MG TABLET Discontinued 2018-09-08 2018-09-15 60834
APO-TRAZODONE TABLETS 100MG 100MG TABLET Discontinued 2018-09-08 2018-09-15 60831
APO-TOLTERODINE 1MG TABLET Discontinued 2018-09-08 2019-01-17 60822
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2018-11-09 60825
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2019-06-12 60828
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-TERAZOSIN 1MG TABLET Discontinued 2017-03-30 2018-02-05 4745

Showing 21 to 40 of 356